{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:12:31Z","timestamp":1786605151415,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":57,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Science and Technology Major Project of China","award":["2012ZX10004701"],"award-info":[{"award-number":["2012ZX10004701"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jmii.2014.03.005","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T14:45:49Z","timestamp":1400856349000},"page":"597-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Recombinant tuberculosis vaccine AEC\/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection"],"prefix":"10.1016","volume":"48","author":[{"given":"Jin-biao","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2014.03.005_bib1","series-title":"Global tuberculosis report","year":"2013"},{"key":"10.1016\/j.jmii.2014.03.005_bib2","series-title":"Tuberculosis vaccine candidates","year":"2013"},{"key":"10.1016\/j.jmii.2014.03.005_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/hv.8570","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: tolerability and immunogenicity in humans","volume":"5","author":"Von Eschen","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jmii.2014.03.005_bib4","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in na\u00efve human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2014.03.005_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jmii.2014.03.005_bib6","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.1016\/j.vaccine.2011.07.094","article-title":"Protection of mice from Mycobacterium tuberculosis by ID87\/GLA-SE, a novel tuberculosis subunit vaccine candidate","volume":"29","author":"Windish","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2014.03.005_bib7","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0264-410X(99)00526-5","article-title":"CpG DNA induces stronger immune responses with less toxicity than other adjuvants","volume":"18","author":"Weeratna","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2014.03.005_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/hv.22755","article-title":"A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis","volume":"9","author":"Asokanathan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jmii.2014.03.005_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1574-695X.2010.00660.x","article-title":"The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants","volume":"59","author":"Chen","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jmii.2014.03.005_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"Scriba","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jmii.2014.03.005_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jmii.2014.03.005_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Gu\u00e9rin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2014.03.005_bib13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG \u0394ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","volume":"204","author":"Desel","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2014.03.005_bib14","first-page":"157","article-title":"Pathogenesis of experimental tuberculosis in animal models","volume":"215","author":"McMurray","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jmii.2014.03.005_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tube.2011.09.003","article-title":"Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis","volume":"92","author":"Grover","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jmii.2014.03.005_bib16","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.0712077106","article-title":"Defined tuberculosis vaccine, Mtb72F\/AS02A, evidence of protection in cynomolgus monkeys","volume":"106","author":"Reed","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmii.2014.03.005_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vaccine.2005.07.078","article-title":"Preclinical testing of new vaccines for tuberculosis: a comprehensive review","volume":"24","author":"Orme","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2014.03.005_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","article-title":"Future vaccination strategies against tuberculosis: thinking outside the box","volume":"33","author":"Kaufmann","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jmii.2014.03.005_bib19","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2014.03.005_bib20","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1128\/AAC.01521-09","article-title":"Evaluation of standard chemotherapy in the guinea pig model of tuberculosis","volume":"54","author":"Ordway","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.03.005_bib21","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.vaccine.2011.12.114","article-title":"Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis","volume":"30","author":"Shang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2014.03.005_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/IAI.70.1.147-152.2002","article-title":"CpG oligodeoxynucleotides enhance host defense during murine tuberculosis","volume":"70","author":"Juffermans","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2014.03.005_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0264-410X(02)00548-0","article-title":"Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs","volume":"21","author":"Hogarth","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2014.03.005_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0041-3879(88)90051-7","article-title":"The protective and allergenic potency of four BCG substrains in use in China determined in two animal models","volume":"69","author":"Wang","year":"1988","journal-title":"Tubercle"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:19Z","timestamp":1761657619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118214000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1684118214000607"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2014.03.005","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant tuberculosis vaccine AEC\/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2014.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}